Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Abstract 3924: Dual COX-2/sEH inhibition enhances immunotherapy and chemotherapy to induce bladder cancer regression

Kimberly Lupita Vazquez, Eva Rothenberger, Weicang Wang, Sung Hee Hwang, Diane R. Bielenberg, Bruce D. Hammock, Dipak Panigrahy

Cancer Res (2024) 84 (6_Supplement): 3924.

https://doi.org/10.1158/1538-7445.AM2024-3924

Published: 22 March 2024

View articletitled, Abstract 3924: Dual COX-2/sEH inhibition enhances immunotherapy and chemotherapy to induce bladder cancer regression

Journal Articles

Abstract 6817: Control of breast cancer via pro-resolving mediators

Sarina A. Virani, Michael Gillespie, Haixia Yang, Diane R. Bielenberg, Mark W. Kieran, Sui Huang, Charles N. Serhan, Dipak Panigrahy

Cancer Res (2024) 84 (6_Supplement): 6817.

https://doi.org/10.1158/1538-7445.AM2024-6817

Published: 22 March 2024

View articletitled, Abstract 6817: Control of breast cancer via pro-resolving mediators

Journal Articles

Abstract 1416: Resolvins enhance immunotherapy to induce Fanconi anemia tumor regression via inflammation resolution

Katherine Quinlivan, Haixia Yang, Diane R. Bielenberg, Susanne I. Wells, Charles N. Serhan, Dipak Panigrahy

Cancer Res (2024) 84 (6_Supplement): 1416.

https://doi.org/10.1158/1538-7445.AM2024-1416

Published: 22 March 2024

View articletitled, Abstract 1416: Resolvins enhance immunotherapy to induce Fanconi anemia tumor regression via inflammation resolution

Journal Articles

Abstract 1135: TP317, a first-in-class resolvin E1 small molecule, potentiates the efficacy of immune checkpoint (ICI) inhibitors in ICI-resistant and ICI-sensitive tumors

Franciele C. Kipper, Eva Rothenberger, Abigail Kelly, Michael Gillespie, Ahmed Attaya, Diane R. Bielenberg, Sui Huang, Lance Pflieger, Frank Sciavolino, Aaron Mathias, Wayne Klohs, John Parkinson, Gary Mathias, Dipak Panigrahy

Cancer Res (2023) 83 (7_Supplement): 1135.

https://doi.org/10.1158/1538-7445.AM2023-1135

Published: 04 April 2023

View articletitled, Abstract 1135: TP317, a first-in-class resolvin E1 small molecule, potentiates the efficacy of immune checkpoint (ICI) inhibitors in ICI-resistant and ICI-sensitive tumors

Journal Articles

Abstract 5133: Targeting the eicosanoid 20-HETE suppresses pancreatic cancer growth and metastasis through regulation of inflammation

Yael Gus-Brautbar, Julia Piwowarski, Jessica A. Casper, Diane R. Bielenberg, Jennifer Cheng, Birgitta Schmidt, Bruce D. Hammock, Darryl C. Zeldin, Mark W. Kieran, Dipak Panigrahy

Cancer Res (2016) 76 (14_Supplement): 5133.

https://doi.org/10.1158/1538-7445.AM2016-5133

Published: 15 July 2016

View articletitled, Abstract 5133: Targeting the eicosanoid 20-HETE suppresses pancreatic cancer growth and metastasis through regulation of inflammation

Journal Articles

Abstract A18: Development of a novel peptide therapeutic that targets ovarian cancer via the tumor microenvironment

Suming Wang, Anna Blois, Tina EI Rayes, Joyce F. Liu, Michelle S. Hirsch, Karsten Gravdal, Diane R. Bielenberg, Lars A. Akslen, Ronny Drapkin, Vivek Mittal, Randolph S. Watnick

Cancer Res (2016) 76 (7_Supplement): A18.

https://doi.org/10.1158/1538-7445.TUMMET15-A18

Published: 26 May 2016

View articletitled, Abstract A18: Development of a novel peptide therapeutic that targets ovarian cancer via the tumor microenvironment

Journal Articles

Abstract 1664: Cancer progression: The failure to resolve

Megan L. Sulciner, Dayna K. Mudge, Diane R. Bielenberg, Ofra Benny, Jesmond Dalli, Sui Huang, Charles N. Serhan, Mark W. Kieran, Dipak Panigrahy

Cancer Res (2014) 74 (19_Supplement): 1664.

https://doi.org/10.1158/1538-7445.AM2014-1664

Published: 01 October 2014

View articletitled, Abstract 1664: Cancer progression: The failure to resolve

Journal Articles

Abstract 4833: The eicosanoid 20-HETE triggers Ras activation, pancreatic cancer growth and metastasis through inflammatory macrophage signaling

Yael Gus-Brautbar, Jessica Casper, Diane R. Bielenberg, Jennifer Cheng, Birgitta Schmidt, Bruce D. Hammock, Darryl C. Zeldin, Mark W. Kieran, Dipak Panigrahy

Cancer Res (2014) 74 (19_Supplement): 4833.

https://doi.org/10.1158/1538-7445.AM2014-4833

Published: 01 October 2014

View articletitled, Abstract 4833: The eicosanoid 20-HETE triggers Ras activation, pancreatic cancer growth and metastasis through inflammatory macrophage signaling

Journal Articles

Abstract 3952: Cytochrome P450-derived eicosanoids regulate pancreatic cancer and metastasis.

Jessica A. Casper, Diane R. Bielenberg, Jennifer Cheng, Birgitta Schmidt, Bruce D. Hammock, Darryl C. Zeldin, Mark W. Kieran, Dipak Panigrahy

Cancer Res (2013) 73 (8_Supplement): 3952.

https://doi.org/10.1158/1538-7445.AM2013-3952

Published: 15 April 2013

View articletitled, Abstract 3952: Cytochrome P450-derived eicosanoids regulate pancreatic cancer and metastasis.

Journal Articles

Abstract 4961: Control of tumor lymphangiogenesis by epoxyeicosanoids.

Dayna K. Mudge, Karolina Serhan, Diane R. Bielenberg, Sung Hee Hwang, Bruce D. Hammock, Mark W. Kieran, Dipak Panigrahy

Cancer Res (2013) 73 (8_Supplement): 4961.

https://doi.org/10.1158/1538-7445.AM2013-4961

Published: 15 April 2013

View articletitled, Abstract 4961: Control of tumor lymphangiogenesis by epoxyeicosanoids.

Journal Articles

Abstract 486: The novel tumor suppressor DIAPH3 governs transition to an amoeboid phenotype

Samantha Morley, Martin H. Hager, Diane R. Bielenberg, Sizhen G. Gao, Matteo Morello, Ilona N. Holcomb, Wennuan Liu, Ghassan Mouneimne, Francesca Demichelis, Jayoung Kim, Keith R. Solomon, Rosalyn M. Adam, William B. Isaacs, Henry N. Higgs, Robert L. Vessella, Dolores Di Vizio, Michael R. Freeman

Cancer Res (2012) 72 (8_Supplement): 486.

https://doi.org/10.1158/1538-7445.AM2012-486

Published: 15 April 2012

View articletitled, Abstract 486: The novel tumor suppressor DIAPH3 governs transition to an amoeboid phenotype

Journal Articles

Abstract 2032: MicroRNA control of tumor cell plasticity in a new tumor metastasis model

Jacqueline Banyard, Arianne M. Wilson, Diane R. Bielenberg, Bruce R. Zetter

Cancer Res (2010) 70 (8_Supplement): 2032.

https://doi.org/10.1158/1538-7445.AM10-2032

Published: 15 April 2010

View articletitled, Abstract 2032: MicroRNA control of tumor cell plasticity in a new tumor metastasis model

Journal Articles

Targeting EGFR activity in tumor-derived endothelial cells.

Dhara N. Amin, Kyoko Hida, Diane R. Bielenberg, Michael Klagsbrun

Cancer Res (2006) 66 (8_Supplement): 1342.

Published: 15 April 2006

View articletitled, Targeting EGFR activity in tumor-derived endothelial cells.

Journal Articles

Behavioral Profiling of Human Transitional Cell Carcinoma Ex vivo

Carlos R. Estrada, Matthew Salanga, Diane R. Bielenberg, W. Bruce Harrell, David Zurakowski, Xuping Zhu, Matthew R. Palmer, Michael R. Freeman, Rosalyn M. Adam

Cancer Res (2006) 66 (6): 3078–3086.

https://doi.org/10.1158/0008-5472.CAN-05-3391

Published: 15 March 2006

View articletitled, Behavioral Profiling of Human Transitional Cell Carcinoma Ex vivo

Journal Articles

Tumor Endothelial Cells Express Epidermal Growth Factor Receptor (EGFR) but not ErbB3 and Are Responsive to EGF and to EGFR Kinase Inhibitors

Dhara N. Amin, Kyoko Hida, Diane R. Bielenberg, Michael Klagsbrun

Cancer Res (2006) 66 (4): 2173–2180.

https://doi.org/10.1158/0008-5472.CAN-05-3387

Published: 17 February 2006

View articletitled, Tumor Endothelial Cells Express Epidermal Growth Factor Receptor (EGFR) but not ErbB3 and Are Responsive to EGF and to EGFR Kinase Inhibitors

Journal Articles

Inhibition of Basic Fibroblast Growth Factor Expression, Angiogenesis, and Growth of Human Bladder Carcinoma in Mice by Systemic Interferon-α Administration

Colin P. N. Dinney, Diane R. Bielenberg, Paul Perrotte, Reuven Reich, Beryl Y. Eve, Corazon D. Bucana, Isaiah J. Fidler

Cancer Res (1998) 58 (4): 808–814.

Published: 01 February 1998

View articletitled, Inhibition of Basic Fibroblast Growth Factor Expression, Angiogenesis, and Growth of Human Bladder Carcinoma in Mice by Systemic Interferon-α Administration

Update search

NARROW

Format

Journal

Article Type

Issue Section

Date

Availability

Abstract 3924: Dual COX-2/sEH inhibition enhances immunotherapy and chemotherapy to induce bladder cancer regression

Abstract 6817: Control of breast cancer via pro-resolving mediators

Abstract 1416: Resolvins enhance immunotherapy to induce Fanconi anemia tumor regression via inflammation resolution

Abstract 1135: TP317, a first-in-class resolvin E1 small molecule, potentiates the efficacy of immune checkpoint (ICI) inhibitors in ICI-resistant and ICI-sensitive tumors

Abstract 5133: Targeting the eicosanoid 20-HETE suppresses pancreatic cancer growth and metastasis through regulation of inflammation

Abstract A18: Development of a novel peptide therapeutic that targets ovarian cancer via the tumor microenvironment

Abstract 1664: Cancer progression: The failure to resolve

Abstract 4833: The eicosanoid 20-HETE triggers Ras activation, pancreatic cancer growth and metastasis through inflammatory macrophage signaling

Abstract 3952: Cytochrome P450-derived eicosanoids regulate pancreatic cancer and metastasis.

Abstract 4961: Control of tumor lymphangiogenesis by epoxyeicosanoids.

Abstract 486: The novel tumor suppressor DIAPH3 governs transition to an amoeboid phenotype

Abstract 2032: MicroRNA control of tumor cell plasticity in a new tumor metastasis model

Targeting EGFR activity in tumor-derived endothelial cells.

Behavioral Profiling of Human Transitional Cell Carcinoma Ex vivo

Tumor Endothelial Cells Express Epidermal Growth Factor Receptor (EGFR) but not ErbB3 and Are Responsive to EGF and to EGFR Kinase Inhibitors

Inhibition of Basic Fibroblast Growth Factor Expression, Angiogenesis, and Growth of Human Bladder Carcinoma in Mice by Systemic Interferon-α Administration

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only